GMP CELL THERAPY CONSUMABLES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

GMP Cell Therapy Consumables Market, By Product Type (Cell Culture Media and Supplements, Cell Separation and Purification Consumables, Cryopreservation Consumables, Cell Transduction Consumables, Other Consumables), By Cell Type (Stem Cells, T-Cells, Natural Killer (NK) Cells, Other Cell Types), By Application (Oncology, Regenerative Medicine, Neurology, Cardiovascular, Immunology, Other Applications), By End User (Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Academic and Research Institutions, Hospitals and Clinics, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Aug 2024
Code : CMI7327
Pages :165
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

GMP Cell Therapy Consumables Market Concentration By players

Close-monitor your Competitor's Move, Request sample copy

Rising incidence of cancer and other infectious diseases

Rising prevalence of chronic medical conditions like cancer and infectious diseases can drive the global GMP cell therapy consumables market growth. According to recent statistics, cancer cases worldwide have increased in last few decades with breast, lung and colorectal cancers topping the charts. Developing nations have observed increase due to lifestyle changes and environmental factors. The economic burden of cancer on healthcare systems worldwide have escalated the need for newer treatment approaches like cell therapies.

Viral diseases such as HIV/AIDS, hepatitis, influenza, and others impact millions globally. Outbreaks of infectious illnesses including swine flu, zika virus and most recently coronavirus further highlight the urgent need for advanced therapies. Cell culture consumables have wide application from vaccine development and testing to production of therapeutic cells for these conditions. Their growth inhibiting properties, controlled environment and sterility assurance are indispensable in manufacturing cell-based products. With rising R&D for cell therapeutics, there has been huge demand for associated GMP-enabled consumables from academic as well as commercial end users.

Key Players Insights